pulmatrix
Pulmatrix
About

Pulmatrix (NASDAQ: PULM) is developing innovative inhaled therapies to address serious pulmonary diseases, including COPD, fungal infections for Cystic Fibrosis patients, and idiopathic pulmonary fibrosis.

56

Ideas

0

Following

237

Followers

0

Liked

0

Watchlist

Real-Time